| Serial Number | 79402309 |
| Word Mark | SEAMLESS |
| Filing Date | Thursday, December 14, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, March 7, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the wording "SEAMLESS" in stylized font next to the letter "S" comprised of curved bands. |
| Goods and Services | Pharmaceutical and biological preparations and active substances, namely, gene therapies and gene-editing therapies for the treatment of genetic diseases or diseases treatable using gene-editing; medical, pharmaceutical and biopharmaceutical preparations and substances, namely gene and gene editing therapies for the treatment of genetic diseases diseases or diseases treatable using gene-editing; pharmaceutical goods and preparations, namely, gene transfer in the nature of programmable recombinases, regulation in the nature of gene editing, gene modulation and delivery in the nature of gene editing for the treatment of genetic diseases and disorders; products and agents, namely, gene and gene editing therapies for medical and veterinary purposes; genome editable enzymes for medical purposes; DNA recombinant enzymes for medical purposes; DNA editable enzymes, namely, recombinases in the nature of gene editing and integrases in the nature of gene editing; genome editable enzymes for medical purposes for the treatment of diseases; DNA recombinant enzymes for medical purposes for the treatment of diseases; DNA editable enzymes, namely, recombinases in the nature of genome manipulation and integrases in the nature of genome manipulation, for the treatment of diseases. |
| Goods and Services | Chemicals for use in industry and science; biological preparations and biological chemical reagents for use in industry and science; all of the foregoing used for non-medical purposes, |
| Goods and Services | Medical analysis relating to the treatment of persons; Assay services, for treatment purposes; Medical services, in relation to the following fields: Genome editing; Genetic counseling; Therapy services; Compilation of medical reports; Providing personalised healthcare and medical information, in relation to the field of genome editing; Providing therapy recommendations; Providing of information and counselling services, in relation to the field of genome editing; Therapy consultancy, in relation to the following fields: Genome editing; Counselling relating to recombinases and integrases for the treatment of diseases. |
| Goods and Services | Scientific and technological services and research, namely, creation in the nature of gene editing and application in the nature of gene therapies of bioinformatic algorithms and models; Science and technology services, namely, scientific and technological research in the field of gene editing technology, scientific development services, technological development in the nature of gene editing technologies and platforms, relating to gene, genome and cell editing and, modulation for the treatment of genetic diseases or diseases treatable using gene-editing, gene modification in the nature of reprogrammable recombinases, engineering in the nature of genome editing, regulation in the nature of genome editing, repair in the nature of gene editing and gene therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; Consultancy services, relating to the following sectors: Gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; Genome engineering services; Scientific research relating to genetics, Scientific research, relating to genome editing; Scientific analytical laboratory services; Medical research laboratory services; Scientific laboratory services; Biological research laboratory services; Scientific research and development; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Identification of target sites for genome editing; Identification of target sites for genome editing by means of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; Screening processes, namely, in silico screening (bioinformatics and computational approaches) and high-throughput screening (HTS), for the identification of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; Research and development for the pharmaceutical industry; Technological consultancy relating to treatment of diseases using DNA editable enzymes, in particular recombinases and integrases. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Seamless Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, August 15, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, August 21, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, August 21, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 22, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, September 3, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 4, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, September 7, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, September 7, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, September 30, 2024 | REFUSAL PROCESSED BY IB |
| Friday, March 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |